Company BriaCell Therapeutics Corp. Nasdaq

Equities

BCTX

CA1079301091

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Bio Therapeutic Drugs

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-26 pm EDT			5-day change	1st Jan Change
2.17 ^USD	-3.12%		+7.43%	-62.91%

Apr. 24	BriaCell Therapeutics to Present Bria-IMT Phase 2 Findings at American Society of Clinical Oncology Annual Meeting	MT
Apr. 10	BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+? and Bria-PROS+? Clinical Candidates for Breast and Prostate Cancer	CI

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops immunotherapies to transform cancer care. The Companyâs lead drug candidate, Bria-IMT, is a cell-based patented immunotherapy that stimulates a patientâs own cancer fighting cells to attack and destroy breast cancer tumors. The Company is advancing its targeted immunotherapy program by prioritizing a Phase II clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor. The Company is focused on conducting a Phase I/IIa clinical trial of Bria-IMT in a combination study with Incyteâs immune PD-1 inhibitor, retifanlimab, in advanced breast cancer. The Company is also developing Bria-OTS, an off-the-shelf personalized approach to whole cell cancer immunotherapy. The Bria-OTS immunotherapy is based on a patientâs HLA-type. Its pipeline also includes Bria-Pros, Bria-Lung, Bria-Mel and sCD80, which are in development to treat various cancers.

Number of employees: 16

Managers	Title	Age	Since
William Williams CEO	Chief Executive Officer	68	16-10-31
Gadi Levin DFI	Director of Finance/CFO	52	16-01-31
Miguel Lopez-Lago CTO	Chief Tech/Sci/R&D Officer	53	21-04-30
Guiseppe Del Priore CTO	Chief Tech/Sci/R&D Officer	62	22-02-15

Members of the board	Title	Age	Since
Martin Schmieg BRD	Director/Board Member	62	16-05-09
Marc Lustig BRD	Director/Board Member	51	21-08-30
Rebecca Taub BRD	Director/Board Member	71	18-03-06
Vaughn Embro-Pantalony BRD	Director/Board Member	66	19-03-17
William Williams CEO	Chief Executive Officer	68	16-10-31
Jane Gross BRD	Director/Board Member	67	21-10-31
Jamieson Bondarenko CHM	Chairman	39	19-02-03

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	15,981,726	14,020,125 ( 87.73 %)	0	87.73 %

Name	Equities	%	Valuation
Marc Lustig 10.39 %	1,660,000	10.39 %	5 M $
Lynwood Capital Management, Inc. 9.890 %	1,580,645	9.890 %	5 M $
Lynwood Capital Management, Inc. 9.135 %	1,460,000	9.135 %	4 M $
William Williams 0.9363 %	149,636	0.9363 %	427 959 $
Redmond Asset Management LLC 0.8358 %	133,569	0.8358 %	382 007 $
Jamieson Bondarenko 0.7500 %	119,856	0.7500 %	342 788 $
KJ Harrison & Partners, Inc. 0.5446 %	87,044	0.5446 %	248 946 $
Morgan Stanley Capital Services LLC 0.4055 %	64,801	0.4055 %	185 331 $
Susquehanna Securities LLC 0.3900 %	62,322	0.3900 %	178 241 $
BMO Bank NA (Investment Management) 0.3222 %	51,495	0.3222 %	147 276 $

Name	Equities	%	Valuation
Armistice Capital LLC -	375,000	-	510 000 $
Redmond Asset Management LLC -	75,000	-	102 000 $

BriaCell Therapeutics Corp.

Bellevue Centre 235 -15th Street

V7T 2X1, West Vancouver

+604 921 1810

http://www.briacell.com

address BriaCell Therapeutics Corp.(BCTX)

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2.93

Average target price

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2.31%	103B
REGENERON PHARMACEUTICALS, INC.	+0.56%	95.28B
ARGENX SE	+1.69%	22.15B
BIONTECH SE	-17.37%	21.02B
GENMAB A/S	-9.30%	18.15B
WUXI APPTEC CO., LTD.	-41.01%	16.74B
BEIGENE, LTD.	-14.85%	16.05B
NEUROCRINE BIOSCIENCES, INC.	+3.21%	13.68B
SAREPTA THERAPEUTICS, INC.	+33.54%	12.17B

Bio Therapeutic Drugs